Cost-effectiveness of treatment strategies for primary operable pancreatic head adenocarcinoma: do we have more scientific evidence to call for further centralization of care?

Ann Surg Oncol. 2013 Jan;20(1):5-6. doi: 10.1245/s10434-012-2615-9.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenocarcinoma / economics*
  • Cost-Benefit Analysis*
  • Female
  • Humans
  • Male
  • Pancreatic Neoplasms / economics*
  • Quality-Adjusted Life Years*